Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 041545MI

RARα Mouse anti-Human, Clone: 9α-9A6, MilliporeSigma™

Catalog No. 041545MI Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
04-154-5MI 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 04-154-5MI Supplier MilliporeSigma Supplier No. 041545
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Anti-RARα Antibody, clone 9α-9A6 is a Mouse Monoclonal Antibody for detection of RARα also known as Retinoic acid receptor alpha polypeptide and has been validated in western blot, immunocytochemistry.
TRUSTED_SUSTAINABILITY

Specifications

Antigen RARα
Applications Immunocytochemistry, Western Blot
Classification Monoclonal
Clone 9α-9A6
Conjugate Unconjugated
Formulation Unpurified mouse monoclonal IgG1κ ascites with 0.05% sodium azide.
Gene Accession No. NP_000955.1
Gene Symbols NR1B1, RAR, RARA, RAR-alpha
Host Species Mouse
Immunogen Recombinant protein corresponding to human RARα.
Purification Method Unpurified
Quantity 100 μL
Primary or Secondary Primary
Target Species Human
Content And Storage −20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
Form Ascites
Isotype IgG1 κ
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.